Peroxisome Proliferator-Activated Receptor / Cross Talks with E2F and Attenuates Mitosis in HRAS-Expressing Cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peroxisome Proliferator-Activated Receptor / Cross Talks with E2F and Attenuates Mitosis in HRAS-Expressing Cells
Authors
Keywords
-
Journal
MOLECULAR AND CELLULAR BIOLOGY
Volume 32, Issue 11, Pages 2065-2082
Publisher
American Society for Microbiology
Online
2012-04-03
DOI
10.1128/mcb.00092-12
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis
- (2011) Jeffrey M. Peters et al. CANCER AND METASTASIS REVIEWS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes
- (2011) Michael G. Borland et al. CELLULAR SIGNALLING
- Biological Function and Prognostic Significance of Peroxisome Proliferator-Activated Receptor in Rectal Cancer
- (2011) L. Yang et al. CLINICAL CANCER RESEARCH
- Survival of Women with Colon Cancer in Relation to Precancer Anthropometric Characteristics: the Iowa Women's Health Study
- (2010) A. E. Prizment et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Insulin resistance and cancer: Epidemiological evidence
- (2010) Shoichiro Tsugane et al. CANCER SCIENCE
- Inflammation and Colon Cancer
- (2010) Janoš Terzić et al. GASTROENTEROLOGY
- B55α PP2A Holoenzymes Modulate the Phosphorylation Status of the Retinoblastoma-related Protein p107 and Its Activation
- (2010) Girish Jayadeva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chemoprevention of Chemically Induced Skin Tumorigenesis by Ligand Activation of Peroxisome Proliferator-Activated Receptor- / and Inhibition of Cyclooxygenase 2
- (2010) B. Zhu et al. MOLECULAR CANCER THERAPEUTICS
- Cellular and Pharmacological Selectivity of the Peroxisome Proliferator-Activated Receptor- / Antagonist GSK3787
- (2010) P. S. Palkar et al. MOLECULAR PHARMACOLOGY
- Obesity and Cancer
- (2010) K. Y. Wolin et al. ONCOLOGIST
- A Mitosis Block Links Active Cell Cycle with Human Epidermal Differentiation and Results in Endoreplication
- (2010) Jennifer Zanet et al. PLoS One
- A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
- (2009) Ji Luo et al. CELL
- Molecular networks as sensors and drivers of common human diseases
- (2009) Eric E. Schadt NATURE
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Ligand Activation of Peroxisome Proliferator–Activated Receptor-β/δ and Inhibition of Cyclooxygenase-2 Enhances Inhibition of Skin Tumorigenesis
- (2009) Moses T. Bility et al. TOXICOLOGICAL SCIENCES
- Metabolic syndrome and risk of subsequent colorectal cancer
- (2009) Raluca Pais et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Quantitative expression patterns of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) protein in mice
- (2008) Elizabeth E. Girroir et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Ligand activation of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) inhibits chemically induced skin tumorigenesis
- (2008) Moses T. Bility et al. CARCINOGENESIS
- Role of peroxisome-proliferator-activated receptor β/δ (PPARβ/δ) in gastrointestinal tract function and disease
- (2008) Jeffrey M. Peters et al. CLINICAL SCIENCE
- Effect of ligand activation of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in human lung cancer cell lines
- (2008) Pengfei He et al. TOXICOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started